Avita Medical
David O'Toole is an accomplished financial executive with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as Chief Financial Officer at AVITA Medical since June 2023, David has previously held similar roles at Opiant Pharmaceuticals, Soleno Therapeutics, Codexis, Response Genetics, and Abraxis BioScience. David's career in finance began after earning a Bachelor of Science degree in Accounting from the University of Arizona, where studies took place from 1979 to 1983.
Avita Medical
AVITA Medical is a publicly listed (NASDAQ: RCEL, ASX:AVH) regenerative medicine company with a technology platform positioned to address unmet medical needs in burns, chronic wounds, and aesthetics indications.